Free Answering Brief in Opposition - District Court of Delaware - Delaware

Case 1:06-cv—OOOO2-G|\/IS Document 11-11 Filed O2/14/2006 Page 1 0f 3

NCas§1l:O6-cyj0O0(Ji2-GMS Document 11-11 Filed 02/14/2006 Page 21off32
€WS c case - 10mG age 0
i , , VV°’
AA ’’,AA» A .;;, _.1,`, N _ A ;
A· »A , “*·
,
,
A e 1 `‘’*
. p z-——’ ’ . · 0:* $>~
A *
j 1 A “ ;’;~
A ,. . , ,//, , 1 %, _

News Release %*t’¥¥§ fiAf
11/>;
A _,VV , .`V, ,, `,'V (YQfAVi€,Q.V,Q,'V,,V,.Aj$ Q View printer—friendly version
i
ir? °ii; << Back i
* [Q , < rv U I as i * V ‘ [ Diomed Holdings, Inc. to Host Conference Call and Announce
A jg ieii V A ···i jjj iVV· Vi`i it V,iA·i»A·i·V ·Vi . Second Quarter 2005 Financial Results on July 28, 2005
ANDOVER, MA, July 14, 2005 - Diomed Holdings, mc. (AMEX: X
.._V DIO), a leading developer and marketer of minimally invasive E
f A/ /ii { medical technologies, including its patented Endovenous Laser
_ 5 AT ji" ` N l’`' %—,?fY`¥*j"?§*; ·’»’ , ` Treatment (EVLT®) for varicose veins, today announced that it will
host a conference call to review the company's second quarter
NEWS ended June 30, 2005 financial results.
i
EVENTS, , The call will be conducted on July 28, 2005, at 10:00 a.m. (ET) and
A V A ' ( ( V ( ( will be hosted by James A. Wylie, Jr., President and Chief Executive
, SEE (Q Officer, and David B. Swank, Chief Financial Officer. The company's
[fd 1 ¢@{Q;i Af, financial results are scheduled to be released earlier that day,
,i.,‘ , ;,.;;,; ,,,,. i i;,;,; ,,.Ql'1;j ,,,' A..A,,{. . ,,,.,,, i; ,.,.,,, g. _,_.,, ,_ g
,AiA ; ,AAi >*~ * - A.,..,___A Q <[1§YL,~g*',’i%4 »'A·Ai’i l Tl €l'<-BS G DB IGS may BCCBSS e C0n erence ca y la lng
,F¥*W*¢¥A# .,‘., , 1 ¤ r ¤ rr th r ll b ¤ ¤ (assi ,
_`,A`'/’ »`”» ff-A,»}?;i}—gfY~,,[Q,?£Y§?[?V '.·i 396-2356 (domestic) or (617) 847-8709 (international), participant
I I- » » »/`' % -1·,/ °»» 1 »V`` % '-V »§ pass code 98164012. The call will also be available via web cast at
I,NFO°i1EqlJ§$T* V www.diomedinc.com.
`’Vr’. if`iiligiiifiiiyiE If you are unable to participate, an audio digital replay of the call ;
{»A` ki will be available from Thursday, July 28, 2005, 1:00 p.m. ET, until
A , . 1 * y Thursday, August 4, 2005, 1:00 p.m. ET. The digital replay can be E
,iA, accessed by dialing 888-286-8010, (domestic) or 617-801-6888 E
YY, (international), using pass code 85886739. A web archive will also i
I .,... ,”.,.,., , ..,,. , ..... .... ...` . ., ,,,,.,.,......, g be available during this time period at www.diomedinc.com. Q
K, A,A,, if KAVV ;. Af, _A,_
" is VAVV AA,— _ — i
,A.j AV?}/{Q1A,,;A,,,j ,»Av, Qi AbOLllZ Diomed g
Diomed develops and commercializes minimally invasive medical §
procedures that use its proprietary laser technologies and
disposable products. Diomed focuses on EndoVenous Laser g
Treatment (EVLT®) for use in varicose vein treatments,
photodynamic therapy (PDT) for use in cancer treatments, and i
http:// ir.diomcdinc.com/phoenixzhtml‘?c= 1 30934&p=irol-ncwsArticlc&ID=7 694... 02/ l 2/2006

NCase{1 :06-c\b0000(?-GIVIS Document 11-11 Filed 02/14/2006 Page 3é>ff32
cws clcasc - 10me age 0
dental and general surgical applications. The EVLT® procedure
the Company‘s related products were cleared by the United States ’ Y '° A A
FDA in January of 2002. Along with lasers and single-use procedure
kits for EVLT®, the Company provides its customers with state of
the art physician training and practice development support.
Additional information is available on the Company's website,
www.evlt.com.
EVLT® is a registered trademark of Diomed Inc. Andover, MA.

l M ~M¤» é
http://ir.diomcdinc.com/phoenix.zhtml‘?c=l 30934&p=irol—newsA1’ticle&ID=7694... 02/12/2006